Clinical Use of a Human Monoclonal Antibody

What is the main route of administration for most drugs?

Which part of the GI tract is considered the most important endocrine system?

What is an example of a drug that can have direct effects on the GI system?

What type of study might be conducted when there is a suspicion of a specific adverse reaction to a drug?

Which system can potentially interact with drugs in the GI tract?

What is the function of gastric mucus in the GI tract?

What is the clinical use of a human monoclonal antibody S.c. in patients with moderate-to-severe ulcerative colitis?

Which adverse effect is associated with the suppression of the TH1 inflammatory response by the human monoclonal antibody S.c.?

What type of adverse infusion reaction is commonly seen with the administration of the human monoclonal antibody S.c.?

What infection is a potential risk due to the use of the human monoclonal antibody S.c.?

Which autoimmune response can develop as an adverse effect of the human monoclonal antibody S.c. treatment?

What type of infection is commonly associated with the reactivation of latent tuberculosis in patients receiving the human monoclonal antibody S.c.?

What adverse effect can be seen in long-term use of proton pump inhibitors (PPIs) related to calcium absorption?

Which of the following is a potential gastrointestinal (GI) adverse effect associated with prolonged inhibition of gastric secretion?

What is a possible neurological adverse effect associated with the use of proton pump inhibitors?

Which condition might be exacerbated in elderly or postmenopausal women due to prolonged use of proton pump inhibitors?

What potential skin-related adverse effect can be associated with the use of proton pump inhibitors?

What interaction with other drugs can be expected when using proton pump inhibitors?